Anne Jones, who is 51, is used to solving any problem that comes her way. She grew up on a farm in southeast Nebraska, where the humid summers and long, harsh winters made farming difficult. Jones was ...

It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t cancel your colonoscopy just yet — that old standby is still more reliable ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...

It's a rite of passage we don't look forward to: Once we turn 45, it's recommended that we get a colonoscopy to screen for polyps and colon cancer. This is especially important as rates of the disease ...

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250922874822/en/ Horror icon Matthew Lillard is teaming ...

The Cologuard test is a first-line colorectal cancer screening test for use in adults age 45 or older who are at average risk for the disease. It is included in national colorectal cancer screening ...

Please provide your email address to receive an email when new articles are posted on . Compared with the original Cologuard test approved by the FDA in 2014, the company’s next-generation test uses ...

The Cologuard Plus test demonstrated 95% sensitivity for colorectal cancer detection at 94% specificity, making it the most accurate noninvasive CRC screening test reported in studies to date Building ...

Forbes contributors publish independent expert analyses and insights. Consumerization is transforming the medical landscape, much like how Netflix (NASDAQ: NFLX) revolutionized video rentals, DoorDash ...

The pending $23 billion sale of Madison-based Exact Sciences to health care giant Abbott centers on Exact Sciences' flagship product: colorectal cancer test Cologuard. Exact Sciences markets Cologuard ...